Literature DB >> 20090666

Shorter dialysis times are associated with higher mortality among incident hemodialysis patients.

Steven M Brunelli1, Glenn M Chertow, Elizabeth D Ankers, Edmund G Lowrie, Ravi Thadhani.   

Abstract

There is an association between hemodialysis session length and mortality independent of the effects of session duration on urea clearance. However, previous studies did not consider changes in session length over time nor did they control for the influence of time-dependent confounding. Using data from a national cohort of 8552 incident patients on thrice-weekly, in-center hemodialysis, we applied marginal structural analysis to determine the association between session length and mortality. Exposure was based on prescribed session length with the outcome being death from any cause. On the 31st day after initiating dialysis, the patients were considered at-risk and remained so until death, censoring, or completion of 1 year on dialysis. On primary marginal structural analysis, session lengths <4 h were associated with a 42% increase in mortality. Sensitivity analyses showed a dose-response relationship between session duration and mortality, and a consistency of findings across prespecified subgroups. Our study suggests that shorter hemodialysis sessions are associated with higher mortality when marginal structural analysis was used to adjust for time-dependent confounding. Further studies are needed to confirm these findings and determine causality.

Entities:  

Mesh:

Year:  2010        PMID: 20090666      PMCID: PMC2864594          DOI: 10.1038/ki.2009.523

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  34 in total

1.  The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose.

Authors:  E G Lowrie; G M Chertow; N L Lew; J M Lazarus; W F Owen
Journal:  Kidney Int       Date:  1999-08       Impact factor: 10.612

2.  Clinical practice guidelines for hemodialysis adequacy, update 2006.

Authors: 
Journal:  Am J Kidney Dis       Date:  2006-07       Impact factor: 8.860

3.  Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients.

Authors:  Jiro Aoki; Yuji Ikari; Hiroyoshi Nakajima; Masaya Mori; Tokuichiro Sugimoto; Mitsuharu Hatori; Shuzou Tanimoto; Eisuke Amiya; Kazuhiro Hara
Journal:  Kidney Int       Date:  2005-01       Impact factor: 10.612

4.  Minimized weight gain between hemodialysis contributes to a reduced risk of death.

Authors:  B G Stegmayr; M Brannstrom; S Bucht; E Dimeny; A Ekspong; B Granroth; K C Grontoft; H Hadimeri; B Holmberg; B Ingman; B Isaksson; G Johansson; K Lindberger; L Lundberg; O Lundstrom; L Mikaelsson; M Mortzell; E Olausson; B Persson; L Svensson; A M Wikdahl
Journal:  Int J Artif Organs       Date:  2006-07       Impact factor: 1.595

5.  Correction for non-compliance in equivalence trials.

Authors:  J M Robins
Journal:  Stat Med       Date:  1998-02-15       Impact factor: 2.373

6.  Importance of treatment time and blood pressure control in achieving long-term survival on dialysis.

Authors:  B Charra; M Calemard; G Laurent
Journal:  Am J Nephrol       Date:  1996       Impact factor: 3.754

7.  Activated injectable vitamin D and hemodialysis survival: a historical cohort study.

Authors:  Ming Teng; Myles Wolf; M Norma Ofsthun; J Michael Lazarus; Miguel A Hernán; Carlos A Camargo; Ravi Thadhani
Journal:  J Am Soc Nephrol       Date:  2005-02-23       Impact factor: 10.121

8.  Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS.

Authors:  R Saran; J L Bragg-Gresham; N W Levin; Z J Twardowski; V Wizemann; A Saito; N Kimata; B W Gillespie; C Combe; J Bommer; T Akiba; D L Mapes; E W Young; F K Port
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

9.  Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients.

Authors:  M R Marshall; B G Byrne; P G Kerr; S P McDonald
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

10.  The dose of hemodialysis and patient mortality.

Authors:  P J Held; F K Port; R A Wolfe; D C Stannard; C E Carroll; J T Daugirdas; W E Bloembergen; J W Greer; R M Hakim
Journal:  Kidney Int       Date:  1996-08       Impact factor: 10.612

View more
  27 in total

1.  Modeled urea distribution volume and mortality in the HEMO Study.

Authors:  John T Daugirdas; Tom Greene; Thomas A Depner; Nathan W Levin; Glenn M Chertow
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

2.  Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials.

Authors:  John D Lantos; David Wendler; Edward Septimus; Sarita Wahba; Rosemary Madigan; Geraldine Bliss
Journal:  Clin Trials       Date:  2015-09-15       Impact factor: 2.486

3.  Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.

Authors:  Christopher T Chan; Tom Greene; Glenn M Chertow; Alan S Kliger; John B Stokes; Gerald J Beck; John T Daugirdas; Peter Kotanko; Brett Larive; Nathan W Levin; Ravindra L Mehta; Michael Rocco; Javier Sanz; Brigitte M Schiller; Phillip C Yang; Sanjay Rajagopalan
Journal:  Circ Cardiovasc Imaging       Date:  2012-02-23       Impact factor: 7.792

4.  Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Francesca Tentori; Jinyao Zhang; Yun Li; Angelo Karaboyas; Peter Kerr; Rajiv Saran; Juergen Bommer; Friedrich Port; Takashi Akiba; Ronald Pisoni; Bruce Robinson
Journal:  Nephrol Dial Transplant       Date:  2012-03-19       Impact factor: 5.992

5.  No Survival Benefit in Octogenarians and Nonagenarians with Extended Hemodialysis Treatment Time.

Authors:  Gang Jee Ko; Yoshitsugu Obi; Melissa Soohoo; Tae Ik Chang; Soo Jeong Choi; Csaba P Kovesdy; Elani Streja; Connie M Rhee; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2018-11-13       Impact factor: 3.754

Review 6.  Rapid ultrafiltration rates and outcomes among hemodialysis patients: re-examining the evidence base.

Authors:  Magdalene M Assimon; Jennifer E Flythe
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-11       Impact factor: 2.894

7.  Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease.

Authors:  Matthew B Rivara; Scott V Adams; Sooraj Kuttykrishnan; Kamyar Kalantar-Zadeh; Onyebuchi A Arah; Alfred K Cheung; Ronit Katz; Miklos Z Molnar; Vanessa Ravel; Melissa Soohoo; Elani Streja; Jonathan Himmelfarb; Rajnish Mehrotra
Journal:  Kidney Int       Date:  2016-08-20       Impact factor: 10.612

8.  Disentangling the ultrafiltration rate-mortality association: the respective roles of session length and weight gain.

Authors:  Jennifer E Flythe; Gary C Curhan; Steven M Brunelli
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-14       Impact factor: 8.237

9.  Balancing the Evidence: How to Reconcile the Results of Observational Studies vs. Randomized Clinical Trials in Dialysis.

Authors:  Jenny I Shen; Erik L Lum; Tara I Chang
Journal:  Semin Dial       Date:  2016-05-21       Impact factor: 3.455

10.  A framework for analysis of research risks and benefits to participants in standard of care pragmatic clinical trials.

Authors:  Stephanie C Chen; Scott Yh Kim
Journal:  Clin Trials       Date:  2016-06-30       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.